Mydecine Innovations Group Announces Common Share Subscription Agreement
29.08.2022 - DENVER, Aug. 29, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group Inc. ('Mydecine' or the 'Company') (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to ... Seite 1
Source: wallstreet-online.de